Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells

Although previous pharmacological and biochemical data support the notion that muscarinic acetylcholine receptors (mAChR) form homo- and heterodimers, the existence of mAChR oligomers in live cells is still a matter of controversy. Here we used bioluminescence resonance energy transfer to demonstrate that M1, M2, and M3 mAChR can form constitutive homo- and heterodimers in living HEK 293 cells. Quantitative bioluminescence resonance energy transfer analysis has revealed that the cell receptor population in cells expressing a single subtype of M1, M2, or M3 mAChR is predominantly composed of high affinity homodimers. Saturation curve analysis of cells expressing two receptor subtypes demonstrates the existence of high affinity M1/M2, M2/M3, and M1/M3 mAChR heterodimers, although the relative affinity values were slightly lower than those for mAChR homodimers. Short term agonist treatment did not modify the oligomeric status of homo- and heterodimers. When expressed in JEG-3 cells, the M2 receptor exhibits much higher susceptibility than the M3 receptor to agonist-induced down-regulation. Coexpression of M3 mAChR with increasing amounts of the M2 subtype in JEG-3 cells resulted in an increased agonist-induced down-regulation of M3, suggesting a novel role of heterodimerization in the mechanism of mAChR long term regulation.

[1]  J. W. Wells,et al.  Effects of adenyl nucleotides and carbachol on cooperative interactions among G proteins. , 1992, Biochemistry.

[2]  L. Potter,et al.  Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.

[3]  J. Nathans,et al.  Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains , 2001, Nature.

[4]  Xiaochun Sun,et al.  Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.

[5]  N. Nathanson,et al.  Identification of a Region Required for Subtype-specific Agonist-induced Sequestration of the m2 Muscarinic Acetylcholine Receptor (*) , 1996, The Journal of Biological Chemistry.

[6]  G. Milligan,et al.  High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor , 2004 .

[7]  S. Yamada,et al.  Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. , 2005, Brain research. Molecular brain research.

[8]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[9]  K. Eidne,et al.  G-protein coupled receptor oligomerization in neuroendocrine pathways , 2003, Frontiers in Neuroendocrinology.

[10]  W. Sadee,et al.  Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. , 1992, The Journal of biological chemistry.

[11]  G. Demontis,et al.  G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.

[12]  J. W. Wells,et al.  Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells. , 2003, Biochemistry.

[13]  R. Ostrom,et al.  M2 muscarinic receptor inhibition of agonist-induced cyclic adenosine monophosphate accumulation and relaxation in the guinea pig ileum. , 1997, The Journal of pharmacology and experimental therapeutics.

[14]  Christopher A Reynolds,et al.  Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.

[15]  C. Johnson,et al.  A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Giorgi,et al.  Paired Activation of Two Components within Muscarinic M3 Receptor Dimers Is Required for Recruitment of β-Arrestin-1 to the Plasma Membrane* , 2005, Journal of Biological Chemistry.

[17]  T. Maniatis,et al.  Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system , 1981, Cell.

[18]  N. Nathanson,et al.  Identification of a Basolateral Sorting Signal for the M3 Muscarinic Acetylcholine Receptor in Madin-Darby Canine Kidney Cells* , 2001, The Journal of Biological Chemistry.

[19]  N. Nathanson,et al.  Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. , 1994, The Journal of biological chemistry.

[20]  C. Brumwell,et al.  Isolation and characterization of monoclonal antibodies specific for the cardiac muscarinic acetylcholine receptor. , 1987, Biochemistry.

[21]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[22]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. W. Wells,et al.  Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. , 1997, Biochemistry.

[24]  N. Nathanson,et al.  In vivo regulation of muscarinic acetylcholine receptor number and function in embryonic chick heart. , 1981, The Journal of biological chemistry.

[25]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[26]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[27]  Y. Furukawa,et al.  Heterogeneous Distribution Of β‐Adrenoceptors and Muscarinic Receptors In The Sinoatrial Node And Right Atrium Of The Dog , 2002, Clinical and experimental pharmacology & physiology.

[28]  Fu-Yue Zeng,et al.  Molecular Aspects of Muscarinic Receptor Dimerization , 2000, Neuropsychopharmacology.

[29]  M. Bouvier,et al.  Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.

[30]  P. Delagrange,et al.  Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.

[31]  K. Kameyama,et al.  Internalization and Down-regulation of Human Muscarinic Acetylcholine Receptor m2 Subtypes , 1998, The Journal of Biological Chemistry.

[32]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[33]  L. Stryer,et al.  The dimeric nature of the gramicidin A transmembrane channel: conductance and fluorescence energy transfer studies of hybrid channels. , 1977, Journal of molecular biology.

[34]  J. W. Wells,et al.  Oligomeric potential of the M2 muscarinic cholinergic receptor , 2004, Journal of neurochemistry.

[35]  N. Nathanson,et al.  Synergistic Regulation of m2 Muscarinic Acetylcholine Receptor Desensitization and Sequestration by G Protein-coupled Receptor Kinase-2 and β-Arrestin-1* , 1997, The Journal of Biological Chemistry.

[36]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[37]  A. G. Roseberry,et al.  Trafficking of M2 Muscarinic Acetylcholine Receptors* , 1999, The Journal of Biological Chemistry.

[38]  R. Moon,et al.  Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization , 2004, Nature Cell Biology.

[39]  N. Nathanson,et al.  Subtype‐specific regulation of the expression and function of muscarinic acetylcholine receptors in embryonic chicken retinal cells , 2002, Journal of neurochemistry.

[40]  M. Schimerlik,et al.  A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[41]  N. Nathanson,et al.  Multiple Topological Domains Mediate Subtype-specific Internalization of the M2 Muscarinic Acetylcholine Receptor* , 2000, The Journal of Biological Chemistry.

[42]  K. Fuxe,et al.  Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.

[43]  Gerda E Breitwieser,et al.  G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.

[44]  F. Ehlert,et al.  Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. , 2003, Biochemical pharmacology.

[45]  M. Scarselli,et al.  The Paired Activation of the Two Components of the Muscarinic M3 Receptor Dimer Is Required for Induction of ERK1/2 Phosphorylation* , 2004, Journal of Biological Chemistry.

[46]  N. Nathanson,et al.  Tissue-specific Regulation of Muscarinic Acetylcholine Receptor Expression during Embryonic Development (*) , 1995, The Journal of Biological Chemistry.